In many South African communities, Traditional Health Practitioners (THPs) are significant participants within a plural health care system. For several years, it has been argued that this role, especially in the context of HIV/AIDS, has not been fully optimised and THPs continue to operate outside the formal biomedical sector, where the latter forms the central means by which public health campaigns are delivered and implemented. In our previous research, we have shown that this separation of the biomedical and traditional sectors perpetuates a low level of understanding of HIV by THPs with adverse consequences for patients and the overall health care system. In this study we investigated whether biomedical/traditional division could be transformed through the involvement of THPs in the distribution of barrier microbicides; the latter are presently under investigation as a means of preventing HIV infection. We concluded that THPs could provide a willing and effective distribution network for the gel-based microbicides; given the large number of THPs and their patients, such a distribution strategy would ensure that microbicides are accessible and adopted relatively quickly within the target communities of the HIV prevention campaigns.
Introduction
In many South African communities, Traditional Health Practitioners (THPs) are significant participants within a plural health care system (Mngqundaniso et al., 2008 and Babb et al., 2007) . For several years, it has been argued that this role, especially in the context of HIV/AIDS, has not been fully optimised (Wreford, 2005) , and THPs continue to operate outside the formal biomedical sector, where the latter forms the central means by which public health campaigns are delivered and implemented. In our previous research, we have shown that this separation of the biomedical and traditional sectors perpetuates a low level of understanding of HIV by THPs with adverse consequences for patients and the overall health care system (Walwyn et al., 2010) . In this study we investigated whether this division could be transformed through the involvement of THPs in the distribution of barrier microbicides; the latter are presently under investigation as a means of preventing HIV infection (for a full listing of all the prevention trials presently in progress, see www.avac.org and the review by Cutler et al. (2008) ).
Objectives of the Study
The purpose of our research was to investigate whether THPs would be willing to play an active role in the promotion of methods for HIV/AIDS prevention, especially the use of the barrier microbicides. The latter are currently being developed to prevent transmission of sexually transmitted infections including HIV/AIDS. The study formed part of broader initiative to improve/broaden conventional prevention methods and assist in upgrading traditional practice with respect to HIV. The project was designed to guide the pharmaceutical sector in whether and how to engage with the traditional sector, and how to develop better approaches for attaining higher levels of cohesion and integration between the traditional and the biomedical sectors. In particular, the project looked at the following important questions: 
Methodology
A total of 25 THPs, equally distributed between the provinces of Gauteng and Limpopo, were interviewed. In all cases, the participants were taken through a semi-structured interview covering an assessment of their understanding of HIV, their treatment approaches and their attitudes towards microbicides. 9(3S):24-26 http://dx.doi.org/10.4314/ajtcam.v9i3S.4
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Results 68% of those interviewed were both interested in, and in favour of, the use of microbicides in the campaign against HIV, especially considering the inherent complications associated with the use of condoms. In particular, it was considered that female patients would welcome a product of this nature should the safety and efficacy concerns be adequately addressed. The remaining THPs were either unsure about (16%), or opposed to (16%), the use of microbicides. Somewhat surprisingly, considering the possible conflict between biomedicine and traditional belief/value systems, over 72% of THPs indicated that they would be prepared to promote the use of microbicides within their practices (Figure 1 ), and to act as a distribution channel for the product, should this be possible within the regulatory structures (Figure 2 ). Some caution was expressed about possible side effects of the product, including fertility problems, cervical cancer and other sexually transmitted diseases (such as Herpes). In another result, it was revealed that THPs did not believe that introduction of microbicides would encounter significant cultural resistance, despite the opinion of previously reported studies on practices such as dry sex (Tallis et al., 2005) . Furthermore the THPs indicated that they would be prepared to participate in training programmes on the use of microbicides. We also noted the following points from the answers to the questionnaire:  patients were counselled on the use of condoms and the latter remained the most widely used means of prevention; however the THPs perceived a general resistance to condom use especially among male clients  most THPs were seeing on average 8 to 10 HIV-positive patients per month  all patients initially assessed as HIV-positive were sent by their THPs for Voluntary Counselling and Testing(VCT); only once the diagnosis had been confirmed by the hospital or clinic was treatment initiated  some THPs considered that microbicides would increase risky sexual behaviour (particularly multiple sexual partners) and their introduction would cause a decrease in condom use  further trials may be required to establish whether substances used routinely to induce dry sex could be administered pre-coital act and in conjunction with the microbicide without affecting the latter's efficacy  women were more likely than men to visit THP and to talk about HIV; the latter remained a taboo subject for many men. 9(3S):24-26
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Discussion
The inclusion of THPs in the distribution channels for barrier microbicides is a matter requiring consideration and acceptance not only by the THPs themselves, but by the medicine regulatory authorities within individual countries, especially those regulations pertaining to the distribution and sale of medicines containing scheduled substances. The extent to which these changes may be required will depend on the scheduling status of the registered product. For instance, microbicides which do not include scheduled substances, such as surfactants and household bacteriostatic agents, may be registered as Schedule 0 or Schedule 1, and would normally be distributed over-the-counter through retail pharmacies and similar outlets. The presence of a registered (referred to as the responsible) pharmacist at such outlets is required before the product can be offered for sale. However, microbicides such as the tenofovir-based gel, which include already registered medicines that have been previously assigned a category 3 or higher schedule, can only be dispensed by a registered pharmacists upon presentation of a doctor's prescription. The inclusion of THPs in the distribution network for a tenofovir-based microbicide would require a number of regulatory changes as follows: The above discussion assumes that the barrier microbicide has already been registered as a pharmaceutical product, which would of itself be a requirement for a product which claims certain health benefits and uses already registered medicinal substances. None of the changes outlined above would be impossible to implement; moreover as already mentioned, the resultant upgrading of the THPs' expertise will be of benefit to both patient and practitioner. Whilst the main objective of this research was to assess the THP response to barrier microbicides, a welcome additional affect would be the resultant value addition to THP practice.
Summary and Conclusions
With certain revisions to the medicines regulatory structure as detailed above, and the implementation of widespread training within THP structures on the use of microbicides, it is concluded that THPs could provide a willing and effective distribution network for the gel-based microbicides presently under development for the prevention of HIV. Given the large number of THPs and their patients, such a distribution strategy would ensure that microbicides could be made available and adopted relatively quickly within the target communities of the HIV prevention campaigns.
